Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$14.6B
sum of reported positions
Reported positions
522
Changes vs prior quarter
505
102 new · 66 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 161 measured positions in 8 quarters, the typical new or larger position finished −2.3 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | 42.9M | $1.45B | 9.9% |
| 3.51M | $914M | 6.2% | |
SELECT SECTOR SPDR TR | 4.23M | $784M | 5.4% |
ISHARES TR | 4.01M | $579M | 4.0% |
| 1.16M | $553M | 3.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.5B | $14.6B |
| Positions | 486 | 522 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 10% |
INVESCO EXCHANGE TRADED FD T |
| 2.31M |
| $491M |
| 3.4% |
| 2.31M | $461M | 3.2% |
| 1.46M | $349M | 2.4% |
| 618K | $335M | 2.3% |
VANGUARD SCOTTSDALE FDS | 3.04M | $323M | 2.2% |
ISHARES TR | 1.28M | $310M | 2.1% |
| 862K | $305M | 2.1% |
| 390K | $297M | 2.0% |
| 795K | $296M | 2.0% |
ISHARES TR | 2.68M | $264M | 1.8% |
| 751K | $256M | 1.7% |
| 646K | $244M | 1.7% |
ISHARES TR | 1.51M | $237M | 1.6% |
| 695K | $201M | 1.4% |
| 808K | $198M | 1.4% |
| 1.37M | $196M | 1.3% |
| 2.08M | $190M | 1.3% |
SELECT SECTOR SPDR TR | 988K | $188M | 1.3% |
| 5.37M | $187M | 1.3% |
ISHARES INC | 4.99M | $172M | 1.2% |
IBM (IBM)
7,291 → 15K shares (+107%)
ISHARES TR
370K → 179K shares (−52%)
SolarEdge (SEDG)
5,919 → 67K shares (+1026%)
Intuitive Surgical (ISRG)
11K → 9,717 shares (−12%)
Space Exploration Technologies (SPCX)
22K shares
Astrazeneca (AZN)
139K → 19K shares (−86%)
CSX Corporation (CSX)
72K → 71K shares (−2%)
Seagate Technology (STX)
2,586 → 3,488 shares (+35%)
Lam Research (LRCX)
4,395 → 7,749 shares (+76%)
Cadence Design Systems (CDNS)
8,145 → 8,785 shares (+8%)
Booking Holdings (BKNG)
153 → 18K shares (+11690%)
Disney (DIS)
44K → 28K shares (−36%)
Gilead Sciences (GILD)
20K → 24K shares (+20%)
Vertex Pharmaceuticals (VRTX)
4,833 → 5,993 shares (+24%)
Quanta Services (PWR)
5,466 → 4,102 shares (−25%)
ASML Holding (ASML)
1,683 → 1,479 shares (−12%)
Philip Morris International (PM)
25K → 16K shares (−35%)
Stryker Corporation (SYK)
15K → 9,108 shares (−38%)
Rockwell Automation (ROK)
5,636 → 5,746 shares (+2%)
Delta Air Lines (DAL)
34K → 29K shares (−14%)
Teradyne (TER)
4,827 → 5,630 shares (+17%)
ISHARES TR
25K shares
Diageo (DEO)
32K → 33K shares (+2%)
Williams Companies (WMB)
41K → 36K shares (−12%)
Zoom Communications (ZM)
25K → 31K shares (+25%)